Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2023

03.05.2023 | Retinal Disorders

Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal aging

verfasst von: Deniz Oncel, Giulia Corradetti, Yu Wakatsuki, Muneeswar Gupta Nittala, Swetha Bindu Velaga, Dwight Stambolian, Margaret A. Pericak-Vance, Jonathan L. Haines, SriniVas R. Sadda

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare drusen size metrics (apical height and basal width) on optical coherence tomography (OCT) B-scans with their size assessed on color photos in eyes with age-related macular degeneration (AMD) and normal aging.

Methods

A total of 508 drusen were evaluated in this analysis. Flash color fundus photos (CFP), infrared reflectance (IR) images, and OCT B-scans obtained at the same visit were evaluated. Individual drusen were identified on CFPs and the diameters of the drusen were measured in planimetric grading software. CFPs were manually registered to the IR image with their corresponding OCT volume. After confirming correspondence between the CFP and OCT, the apical height and basal width of the same drusen were measured on OCT B-scans.

Results

Drusen were divided into small, medium, large, and very large categories based on their diameter on the CFP images (< 63, 63 to 124, 125 to 249, and \(\ge\) 250 μm, respectively). The OCT apical height of small drusen on CFP ranged from 20 to 31 μm, while medium drusen ranged from 31 to 46 μm, large drusen ranged from 45 μm to 111 µm, and very large drusen ranged from 55 μm to 208 μm. The OCT basal width measured < 99 μm in small drusen, from 99 to 143 μm in medium drusen, from 141 to 407 µm in large drusen, and > 209 µm in very large drusen.

Conclusion

Drusen of different size categories on color photographs may also be separated according to their apical height and basal width on OCT. The apical height and basal width ranges defined in this analysis may be of value in the design of an OCT-based grading scale for AMD.
Literatur
1.
Zurück zum Zitat Friedman DS, O’Colmain BJ, Muñoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572CrossRefPubMed Friedman DS, O’Colmain BJ, Muñoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564–572CrossRefPubMed
2.
Zurück zum Zitat Bressler NM, Bressler SB, Congdon NG et al (2003) Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 121:1621–1624CrossRefPubMed Bressler NM, Bressler SB, Congdon NG et al (2003) Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 121:1621–1624CrossRefPubMed
3.
Zurück zum Zitat Age-Related Eye Disease Study Research Group (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132:668–681CrossRef Age-Related Eye Disease Study Research Group (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132:668–681CrossRef
4.
Zurück zum Zitat Meyer CH, Saxena S, Sadda SR (2017) Spectral domain optical coherence tomography in macular diseases. Springer India Meyer CH, Saxena S, Sadda SR (2017) Spectral domain optical coherence tomography in macular diseases. Springer India
6.
Zurück zum Zitat Ferris FL 3rd, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851CrossRefPubMed Ferris FL 3rd, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851CrossRefPubMed
7.
Zurück zum Zitat Zhang X, Sivaprasad S (2021) Drusen and pachydrusen: the definition, pathogenesis, and clinical significance. Eye 35:121–133CrossRefPubMed Zhang X, Sivaprasad S (2021) Drusen and pachydrusen: the definition, pathogenesis, and clinical significance. Eye 35:121–133CrossRefPubMed
8.
Zurück zum Zitat Klein R, Klein BEK, Tomany SC et al (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109:1767–1779CrossRefPubMed Klein R, Klein BEK, Tomany SC et al (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109:1767–1779CrossRefPubMed
9.
Zurück zum Zitat Davis MD, Gangnon RE, Lee L-Y et al (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123:1484–1498CrossRefPubMed Davis MD, Gangnon RE, Lee L-Y et al (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123:1484–1498CrossRefPubMed
10.
Zurück zum Zitat Wang JJ, Foran S, Smith W, Mitchell P (2003) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121:658–663CrossRefPubMed Wang JJ, Foran S, Smith W, Mitchell P (2003) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121:658–663CrossRefPubMed
11.
Zurück zum Zitat Ferris FL, Davis MD, Clemons TE et al (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123:1570–1574CrossRefPubMed Ferris FL, Davis MD, Clemons TE et al (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123:1570–1574CrossRefPubMed
13.
Zurück zum Zitat Yehoshua Z, Wang F, Rosenfeld PJ et al (2011) Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 118:2434–2441CrossRefPubMed Yehoshua Z, Wang F, Rosenfeld PJ et al (2011) Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 118:2434–2441CrossRefPubMed
14.
Zurück zum Zitat Nittala MG, Song YE, Sardell R et al (2019) Amish Eye Study: baseline spectral domain optical coherence tomography characteristics of age-related macular degeneration. Retina 39:1540–1550CrossRefPubMedPubMedCentral Nittala MG, Song YE, Sardell R et al (2019) Amish Eye Study: baseline spectral domain optical coherence tomography characteristics of age-related macular degeneration. Retina 39:1540–1550CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gabriele ML, Wollstein G, Ishikawa H et al (2010) Three dimensional optical coherence tomography imaging: advantages and advances. Prog Retin Eye Res 29:556–579CrossRefPubMedPubMedCentral Gabriele ML, Wollstein G, Ishikawa H et al (2010) Three dimensional optical coherence tomography imaging: advantages and advances. Prog Retin Eye Res 29:556–579CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Phadikar P, Saxena S, Ruia S et al (2017) The potential of spectral domain optical coherence tomography imaging based retinal biomarkers. Int J Retina Vitreous 3:1CrossRefPubMedPubMedCentral Phadikar P, Saxena S, Ruia S et al (2017) The potential of spectral domain optical coherence tomography imaging based retinal biomarkers. Int J Retina Vitreous 3:1CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Holz FG, Sadda SR, Staurenghi G et al (2017) Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology 124:464–478CrossRefPubMed Holz FG, Sadda SR, Staurenghi G et al (2017) Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology 124:464–478CrossRefPubMed
19.
Zurück zum Zitat Sadda SR, Guymer R, Holz FG et al (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology 125:537–548CrossRefPubMed Sadda SR, Guymer R, Holz FG et al (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology 125:537–548CrossRefPubMed
20.
Zurück zum Zitat Farsiu S, Chiu SJ, O’Connell RV et al (2014) Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology 121:162–172CrossRefPubMed Farsiu S, Chiu SJ, O’Connell RV et al (2014) Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology 121:162–172CrossRefPubMed
21.
Zurück zum Zitat Yu JJ, Agrón E, Clemons TE et al (2019) Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology 126:261–273CrossRefPubMed Yu JJ, Agrón E, Clemons TE et al (2019) Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology 126:261–273CrossRefPubMed
22.
Zurück zum Zitat Nittala MG, Ruiz-Garcia H, Sadda SR (2012) Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 53:8319–8324CrossRefPubMed Nittala MG, Ruiz-Garcia H, Sadda SR (2012) Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 53:8319–8324CrossRefPubMed
23.
Zurück zum Zitat Freeman SR, Kozak I, Cheng L et al (2010) Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina 30:431–435CrossRefPubMed Freeman SR, Kozak I, Cheng L et al (2010) Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina 30:431–435CrossRefPubMed
24.
Zurück zum Zitat de Sisternes L, Simon N, Tibshirani R et al (2014) Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. Invest Ophthalmol Vis Sci 55:7093–7103CrossRefPubMed de Sisternes L, Simon N, Tibshirani R et al (2014) Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. Invest Ophthalmol Vis Sci 55:7093–7103CrossRefPubMed
25.
Zurück zum Zitat Dieaconescu DA, Dieaconescu IM, Williams MA et al (2012) Drusen height and width are highly predictive markers for progression to neovascular AMD. Invest Ophthalmol Vis Sci 53:2910–2910 Dieaconescu DA, Dieaconescu IM, Williams MA et al (2012) Drusen height and width are highly predictive markers for progression to neovascular AMD. Invest Ophthalmol Vis Sci 53:2910–2910
26.
Zurück zum Zitat Gregori G, Yehoshua Z, Garcia Filho CA, de A, et al (2014) Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 55:7662–7668CrossRefPubMedPubMedCentral Gregori G, Yehoshua Z, Garcia Filho CA, de A, et al (2014) Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 55:7662–7668CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Jain N, Farsiu S, Khanifar AA et al (2010) Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci 51:4875–4883CrossRefPubMedPubMedCentral Jain N, Farsiu S, Khanifar AA et al (2010) Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci 51:4875–4883CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Göbel AP, Fleckenstein M, Heeren TFC et al (2016) In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging. Graefes Arch Clin Exp Ophthalmol 254:59–67CrossRefPubMed Göbel AP, Fleckenstein M, Heeren TFC et al (2016) In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging. Graefes Arch Clin Exp Ophthalmol 254:59–67CrossRefPubMed
29.
Zurück zum Zitat Cheung CMG, Shi Y, Tham YC et al (2018) Correlation of color fundus photograph grading with risks of early age-related macular degeneration by using automated OCT-derived drusen measurements. Sci Rep 8:12937CrossRefPubMedPubMedCentral Cheung CMG, Shi Y, Tham YC et al (2018) Correlation of color fundus photograph grading with risks of early age-related macular degeneration by using automated OCT-derived drusen measurements. Sci Rep 8:12937CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Diniz B, Ribeiro R, Heussen FM et al (2014) Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysis. Retina 34:55–62CrossRefPubMed Diniz B, Ribeiro R, Heussen FM et al (2014) Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysis. Retina 34:55–62CrossRefPubMed
31.
Zurück zum Zitat Laura K, Laurie D, Min S et al (2016) Predictors of macular atrophy detected by fundus autofluorescence in patients with neovascular age-related macular degeneration after long-term ranibizumab treatment. Ophthalmic Surg Lasers Imaging Retina 47:224–231CrossRef Laura K, Laurie D, Min S et al (2016) Predictors of macular atrophy detected by fundus autofluorescence in patients with neovascular age-related macular degeneration after long-term ranibizumab treatment. Ophthalmic Surg Lasers Imaging Retina 47:224–231CrossRef
32.
Zurück zum Zitat Nittala MG, Amirhossein H, Wong WT et al (2015) Image scaling difference between a confocal scanning laser ophthalmoscope and a flash fundus camera. Ophthalmic Surg Lasers Imaging Retina 46:872–879CrossRefPubMed Nittala MG, Amirhossein H, Wong WT et al (2015) Image scaling difference between a confocal scanning laser ophthalmoscope and a flash fundus camera. Ophthalmic Surg Lasers Imaging Retina 46:872–879CrossRefPubMed
33.
Zurück zum Zitat Yehoshua Z, Gregori G, Sadda SR et al (2013) Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 54:2429–2434CrossRefPubMedPubMedCentral Yehoshua Z, Gregori G, Sadda SR et al (2013) Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 54:2429–2434CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Kim DY, Loo J, Farsiu S, Jaffe GJ (2021) Comparison of single drusen size on color fundus photography and spectral-domain optical coherence tomography. Retina 41:1715–1722CrossRefPubMed Kim DY, Loo J, Farsiu S, Jaffe GJ (2021) Comparison of single drusen size on color fundus photography and spectral-domain optical coherence tomography. Retina 41:1715–1722CrossRefPubMed
Metadaten
Titel
Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal aging
verfasst von
Deniz Oncel
Giulia Corradetti
Yu Wakatsuki
Muneeswar Gupta Nittala
Swetha Bindu Velaga
Dwight Stambolian
Margaret A. Pericak-Vance
Jonathan L. Haines
SriniVas R. Sadda
Publikationsdatum
03.05.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-023-06088-z

Weitere Artikel der Ausgabe 9/2023

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.